|
Invited Speakers:
|
|
Berengere Dumotier ASSOCIATE DIRECTOR, Novartis
Davide Gianni Senior Director, Astrazeneca
Geoffrey Kerchner Vice President, Global Head Early Development Neuroscience & Rare Diseases, F. Hoffmann-La Roche, Ltd.
Irene Choi Head of Drug Discovery, Verge Genomics
Janet Brownlees Senior Director, Merck Sharpe and Dohme
Johan Luthman Executive Vice President of R&D, Lundbeck
Sanne Glad Scientific Director, Amgen Research Copenhagen
Amelie Joffrin Investigator, Chemical Biology, GSK
Andrew Beggs Professor, University of Birmingham
Anna Vulpetti Associate Director, Novartis
Arianna Sabò Head of R&D, QUANTRO Therapeutics GmbH
Borislav Dejanovic Senior Director, Vigil Neuroscience
Carl Poelking Associate Director, Astex
Daohong Zhou Professor, UTHSA
Dave Bearss CEO, Halia
Diana Zindel Associate Director, AstraZeneca
Domagoj Vucic Senior Fellow, Genentech
Emma Davies Associate Director - Preclinical, Healx
Eric Goedken Senior Principal Research Scientist, Dermatology, Immunology Discovery, AbbVie
Filip Roudnicky Senior Principal Scientist, Roche
Gebhard Thoma Associate Director, Novartis
Gergely Toth CEO, Cantabio Pharmaceuticals
Giovanni Spagnolli CTO, Sibylla Biotech
Graham Dempsey Chief Scientific Officer, Quiver Bioscience
Gregori Gerebtzoff Director, Novartis
Gregory Hollingworth Director, Chemistry and TPD/Proximity Initiative co-Lead, Novartis
Hai Rao Professor and Chair of Biochemistry, Southern University of Science and Technology
James Overell Group Medical Director, Roche
Jennifer Petter Founder & CSO, FogPharma
Jon Lea Team Leader, GSK
Jonathan Mason Senior Research Fellow, Sosei Heptares
Jose Luis Molinuevo VP Head of Exp Med, Lundbeck
Julian Röwe Senior Scientist, Babraham Institute
Kerstin Hofer Senior Scientist and Matrix Lead, Roche
Ludovic Collin Head of Neuroimmunology, Roche
Manuel Stritt Head Scientific Computing Drug Discovery, Idorsia Pharmaceuticals
Mark McAlister Director of Biophysics, AstraZeneca
Markus Schade Principal Scientist, AstraZeneca
Mirko Messa Associate Director, AstraZeneca
Mo Lotfollahi Director Of Machine Learning Research, Relation Therapeutics
Morten Grunnet Vice President, Head of Neuroscience, Professor, Lundbeck
Nathalie Cartier-Lacave Vice President Neurobiology, CNS Sector Lead, Askbio Paris Site Head, AskBio
Nils Hansen Chief Executive Officer, Vipergen
Oliver Hucke Associate Director, Boehringer Ingelheim
Olivier Loiseleur Senior Team Leader, Syngenta
Paulina Kolasinska-Zwierz Principal Scientist, Alchemab Therapeutics
Peter Brandt Head of Chemistry, Beactica Therapeutics
Richard Lewis Director, Data Science, Novartis
Robert Fremeau Founder and CSO, BrainStorm Therapeutics, Inc.
Roberto Villaseñor Principal Scientist, Roche
Robin Löving CSO, Salipro Biotech
Simona Cotesta Director, Novartis
Slim Chiha Co-Founder & CEO, PROSION Therapeutics
Takhar Kasumov Associate Professor, Northeastern Ohio University
Tarek Alec Samad Senior Vice President, Global Head of Research, Corporate Patents & Trademarks, Lundbeck
Ulrike Künzel Associate Principal Scientist, Astrazeneca
Xinxin Gao Principal Scientific Manager, Genentech
Zoran Rankovic Director, CBT Chemistry Centers, St Jude Children's Research Hospital
|
|
